Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Vaginal PAMG-1 Detection by PartoSure Test in Preterm Delivery Threat in Actual Clinical Situation: Randomized Controlled Trial

NCT03675061 is registered in ClinicalTrials.gov with University Hospital, Brest as lead sponsor.

NCT NCT03675061
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03675061 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Vaginal PAMG-1 Detection by PartoSure Test in Preterm Delivery Threat in Actual Clinical Situation: Randomized Controlled Trial
Lead sponsor
University Hospital, Brest
Phase
Not applicable
Overall status
Completed
Start date
December 11, 2018
Completion date
February 23, 2021
Enrollment
128 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pregnancy preterm